General Electric Company’s (GE - Free Report) business unit — GE Healthcare — recently rolled out microscope with extensive imaging capabilities for a wide range of research projects. Dubbed as DeltaVision OMX Flex, the microscope is designed as a multichannel imaging platform for structured illumination microscopy. It also incorporates EDGE confocal technology.
Notably, the advanced microscopy tools embedded into the super-resolution microscope help in providing clear and detailed image resolution of cellular structures, supporting research projects in several fields including virology and molecular and cellular biology among others. As noted by the company, the DeltaVision OMX Flex is capable of capturing cell division details with high precision and contrast.
Powered with a laser-based high-content imaging system — IN Cell 6500HS EDGE confocal technology — the DeltaVision OMX Flex is capable of providing improved contrast through increased depth of complex 3D sample images. Also, the microscope facilitates easy change of imaging modes, allowing researchers to shift from a micro- to a nanoview of cells, tissues and organelles.
In addition, the EDGE confocal technology helps to calculate and eliminate the out-of-focus light, which otherwise hampers image contrast. This feature provides an edge to the DeltaVision OMX Flex microscope over its traditional counterparts. Notably, the enhanced quality of image is particularly important for cells, which are developed in 3D culture like organoids and spheroids.
Our Take
General Electric intends to become more competent by focusing on core businesses. In June 2018, it announced its plan to become a high-tech industrial company focused on Aviation, Power and Renewable Energy. Although the company is working toward improving operations and lowering costs in the Power segment, persistent challenges in the segment remain a concern.
Year to date, the Zacks Rank #3 (Hold) company’s share price has increased 24% compared with 19.8% growth recorded by the industry.
Key Picks
Some better-ranked stocks from the same space are Federal Signal Corporation (FSS - Free Report) , Carlisle Companies Incorporated (CSL - Free Report) and United Technologies Corporation . While Federal Signal sports a Zacks Rank #1 (Strong Buy), Carlisle and United Technologies carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Federal Signal surpassed estimates in each of the preceding four quarters, the average positive earnings surprise being 16.48%.
Carlisle outpaced estimates thrice in the preceding four quarters, the average positive earnings surprise being 17.16%.
United Technologies outpaced estimates in each of the preceding four quarters, the average positive earnings surprise being 13.19%.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
General Electric Company’s (GE - Free Report) business unit — GE Healthcare — recently rolled out microscope with extensive imaging capabilities for a wide range of research projects. Dubbed as DeltaVision OMX Flex, the microscope is designed as a multichannel imaging platform for structured illumination microscopy. It also incorporates EDGE confocal technology.
Notably, the advanced microscopy tools embedded into the super-resolution microscope help in providing clear and detailed image resolution of cellular structures, supporting research projects in several fields including virology and molecular and cellular biology among others. As noted by the company, the DeltaVision OMX Flex is capable of capturing cell division details with high precision and contrast.
Powered with a laser-based high-content imaging system — IN Cell 6500HS EDGE confocal technology — the DeltaVision OMX Flex is capable of providing improved contrast through increased depth of complex 3D sample images. Also, the microscope facilitates easy change of imaging modes, allowing researchers to shift from a micro- to a nanoview of cells, tissues and organelles.
In addition, the EDGE confocal technology helps to calculate and eliminate the out-of-focus light, which otherwise hampers image contrast. This feature provides an edge to the DeltaVision OMX Flex microscope over its traditional counterparts. Notably, the enhanced quality of image is particularly important for cells, which are developed in 3D culture like organoids and spheroids.
Our Take
General Electric intends to become more competent by focusing on core businesses. In June 2018, it announced its plan to become a high-tech industrial company focused on Aviation, Power and Renewable Energy. Although the company is working toward improving operations and lowering costs in the Power segment, persistent challenges in the segment remain a concern.
Year to date, the Zacks Rank #3 (Hold) company’s share price has increased 24% compared with 19.8% growth recorded by the industry.
Key Picks
Some better-ranked stocks from the same space are Federal Signal Corporation (FSS - Free Report) , Carlisle Companies Incorporated (CSL - Free Report) and United Technologies Corporation . While Federal Signal sports a Zacks Rank #1 (Strong Buy), Carlisle and United Technologies carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Federal Signal surpassed estimates in each of the preceding four quarters, the average positive earnings surprise being 16.48%.
Carlisle outpaced estimates thrice in the preceding four quarters, the average positive earnings surprise being 17.16%.
United Technologies outpaced estimates in each of the preceding four quarters, the average positive earnings surprise being 13.19%.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on GE - FREE
Get the latest research report on CSL - FREE
Get the latest research report on FSS - FREE